The DOI matches its Crossref record; 305 of the 305 references it cites were found in a registry or an index.
MATURE T LYMPHOCYTE APOPTOSIS—Immune Regulation in a Dynamic and Unpredictable Antigenic Environment
Abstract
▪ Abstract Apoptosis of mature T lymphocytes preserves peripheral homeostasis and tolerance by countering the profound changes in the number and types of T cells stimulated by diverse antigens. T cell apoptosis occurs in at least two major forms: antigen-driven and lymphokine withdrawal. These forms of death are controlled in response to local levels of IL-2 and antigen in a feedback mechanism termed propriocidal regulation. Active antigen-driven death is mediated by the expression of death cytokines such as FasL and TNF. These death cytokines engage specific receptors that assemble caspase-activating protein complexes. These signaling complexes tightly regulate cell death but are vulnerable to inherited defects. Passive lymphokine withdrawal death may result from the cytoplasmic activation of caspases that is regulated by mitochondria and the Bcl-2 protein. The human disease, Autoimmune Lymphoproliferative Syndrome (ALPS) is due to dominant-interfering mutations in the Fas/APO-1/CD95 receptor and other components of the death pathway. The study of ALPS patients reveals the necessity of apoptosis for preventing autoimmunity and allows the genetic investigation of apoptosis in humans. Immunological, cellular, and molecular evidence indicates that throughout the life of a T cell, apoptosis may be evoked in excessive, harmful, or useless clonotypes to preserve a healthy and balanced immune system.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–305 of 305
Fas- and FasL-deficient mice are resistant to induction of autoimmune encephalomyelitis
Waldner, H., Sobel, R. A., Howard, E., & Kuchroo, V. K. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.159.7.3100 · Cited by 199
Park, C. G., Lee, S. Y., Kandala, G., Lee, S. Y., & Choi, Y. (1996) · Immunity · doi:10.1016/s1074-7613(00)80484-7 · Cited by 197
Lee, S. Y., Lee, S. Y., & Choi, Y. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.185.7.1275 · Cited by 195
CD28 costimulation inhibits TCR-induced apoptosis during a primary T cell response
Radvanyi, L. G., Shi, Y., Vaziri, H., Sharma, A., Dhala, R., Mills, G. B., & Miller, R. G. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.156.5.1788 · Cited by 194
HIV-1 Directly Kills CD4+ T Cells by a Fas-independent Mechanism
Gandhi, R. T., Chen, B. K., Straus, S. E., Dale, J. K., Lenardo, M. J., & Baltimore, D. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.187.7.1113 · Cited by 194
Self-citationFas antigen and p55 TNF receptor signal apoptosis through distinct pathways.
Wong, G. H. W., & Goeddel, D. V. (1994) · The Journal of Immunology · doi:10.4049/jimmunol.152.4.1751 · Cited by 193
The Genetics of Programmed Cell Death in the Nematode Caenorhabditis elegans
Horvitz, H. R., Shaham, S., & Hengartner, M. O. (1994) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.1994.059.01.042 · Cited by 193
A Fas-associated protein factor, FAF1, potentiates Fas-mediated apoptosis.
Chu, K., Niu, X., & Williams, L. T. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.25.11894 · Cited by 193
Fas and the art of lymphocyte maintenance.
Lenardo, M. J. (1996) · The Journal of experimental medicine · doi:10.1084/jem.183.3.721 · Cited by 192
Self-citationBettinardi, A., Brugnoni, D., Quiròs-Roldan, E., Malagoli, A., La Grutta, S., Correra, A., & Notarangelo, L. D. (1997) · Blood · doi:10.1182/blood.v89.3.902 · Cited by 190
Estaquier, J., Tanaka, M., Suda, T., Nagata, S., Golstein, P., & Ameisen, J. (1996) · Blood · doi:10.1182/blood.v87.12.4959.bloodjournal87124959 · Cited by 187
Van Parijs, L., Biuckians, A., Ibragimov, A., Alt, F. W., Willerford, D. M., & Abbas, A. K. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.158.8.3738 · Cited by 184
Differential ability of T cell subsets to undergo activation-induced cell death
Varadhachary, A. S., Perdow, S. N., Hu, C., Ramanarayanan, M., & Salgame, P. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.11.5778 · Cited by 183
Clinical, immunological, and pathological consequences of Fas-deficient conditions
Le Deist, F., Emile, J.-F., Rieux-Laucat, F., Benkerrou, M., Roberts, I., Brousse, N., & Fischer, A. (1996) · The Lancet · doi:10.1016/s0140-6736(96)02293-3 · Cited by 183
Katsikis, P. D., Garcia-Ojeda, M. E., Torres-Roca, J. F., Tijoe, I. M., Smith, C. A., Herzenberg, L. A., & Herzenberg, L. A. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.8.1365 · Cited by 182
Regulation of thymocyte development from immature progenitors
Zúñiga-Pflücker, J. C., & Lenardo, M. J. (1996) · Current Opinion in Immunology · doi:10.1016/s0952-7915(96)80060-4 · Cited by 177
Self-citationTyrosine kinase activation provides an early and requisite signal for Fas-induced apoptosis.
Eischen, C. M., Dick, C. J., & Leibson, P. J. (1994) · The Journal of Immunology · doi:10.4049/jimmunol.153.5.1947 · Cited by 174
Deng, G., & Podack, E. R. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.6.2189 · Cited by 173
Bcl-2 blocks glucocorticoid- but not Fas- or activation-induced apoptosis in a T cell hybridoma
Memon, S. A., Moreno, M. B., Petrak, D., & Zacharchuk, C. M. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.155.10.4644 · Cited by 172
Dianzani, U., Bragardo, M., DiFranco, D., Alliaudi, C., Scagni, P., Buonfiglio, D., Redoglia, V., Bonissoni, S., Correra, A., Dianzani, I., et al. (1997) · Blood · doi:10.1182/blood.v89.8.2871 · Cited by 169
Fas-activated serine/threonine kinase (FAST) phosphorylates TIA-1 during Fas-mediated apoptosis.
Tian, Q., Taupin, J., Elledge, S., Robertson, M., & Anderson, P. (1995) · The Journal of experimental medicine · doi:10.1084/jem.182.3.865 · Cited by 167
Peter, M. E., Kischkel, F. C., Scheuerpflug, C. G., Medema, J. P., Debatin, K., & Krammer, P. H. (1997) · European Journal of Immunology · doi:10.1002/eji.1830270523 · Cited by 166
Expression of Bcl-2, Bcl-x, and Bax after T cell activation and IL-2 withdrawal
Broome, H. E., Dargan, C. M., Krajewski, S., & Reed, J. C. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.155.5.2311 · Cited by 163
Russell, J. H., & Wang, R. (1993) · European Journal of Immunology · doi:10.1002/eji.1830230951 · Cited by 158
Toyoshima, F., Moriguchi, T., & Nishida, E. (1997) · The Journal of Cell Biology · doi:10.1083/jcb.139.4.1005 · Cited by 156
Kolesnick, R. N., Haimovitz‐Friedman, A., & FUKS, Z. Y. (1994) · Biochemistry and Cell Biology · doi:10.1139/o94-063 · Cited by 155
Mariani, S. M., Matiba, B., Armandola, E. A., & Krammer, P. H. (1997) · The Journal of Cell Biology · doi:10.1083/jcb.137.1.221 · Cited by 155
A Regulatory Role for TRAF1 in Antigen-induced Apoptosis of T Cells
Speiser, D. E., Lee, S. Y., Wong, B., Arron, J. R., Santana, A., Kong, Y., Ohashi, P. S., & Choi, Y. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.185.10.1777 · Cited by 155
Fas and tumor necrosis factor receptor-mediated cell death: similarities and distinctions.
Clement, M., & Stamenkovic, I. (1994) · The Journal of Experimental Medicine · doi:10.1084/jem.180.2.557 · Cited by 153
Varfolomeev, E. E., Boldin, M., Goncharov, T. M., & Wallach, D. (1996) · The Journal of Experimental Medicine · doi:10.1084/jem.183.3.1271 · Cited by 153
Sloand, E. M., Young, N. S., Kumar, P. N., Weichold, F., Sato, T., & Maciejewski, J. P. (1997) · Blood · doi:10.1182/blood.v89.4.1357 · Cited by 152
Sabelko, K. A., Kelly, K. A., Nahm, M. H., Cross, A. H., & Russell, J. H. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.159.7.3096 · Cited by 150
Maria, R. D., Rippo, M. R., Schuchman, E. H., & Testi, R. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.187.6.897 · Cited by 145
Contribution of Fas ligand to T cell-mediated hepatic injury in mice
Seino, K., Kayagaki, N., Takeda, K., Fukao, K., Okumura, K., & Yagita∥, H. (1997) · Gastroenterology · doi:10.1053/gast.1997.v113.pm9322527 · Cited by 142
Receptor-induced death in human natural killer cells: involvement of CD16.
Ortaldo, J. R., Mason, A. T., & O’Shea, J. J. (1995) · The Journal of Experimental Medicine · doi:10.1084/jem.181.1.339 · Cited by 142
Mutation of CD95 (Fas/Apo-1) Gene in Adult T-Cell Leukemia Cells
Tamiya, S., Etoh, K., Suzushima, H., Takatsuki, K., & Matsuoka, M. (1998) · Blood · doi:10.1182/blood.v91.10.3935 · Cited by 142
Growth factors can enhance lymphocyte survival without committing the cell to undergo cell division.
Boise, L., Minn, A. J., June, C. H., Lindsten, T., & Thompson, C. B. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.12.5491 · Cited by 141
gld/gld mice are unable to express a functional ligand for Fas
Ramsdell, F., Seaman, M. S., Miller, R. E., Tough, T. W., Alderson, M. R., & Lynch, D. H. (1994) · European Journal of Immunology · doi:10.1002/eji.1830240422 · Cited by 139
Tumor necrosis factor receptor p55 mediates deletion of peripheral cytotoxic T lymphocytes in vivo
Speiser, D. E., Sebzda, E., Ohteki, T., Bachmann, M. F., Pfeffer, K., Mak, T. W., & Ohashi, P. S. (1996) · European Journal of Immunology · doi:10.1002/eji.1830261235 · Cited by 136
Involvement of multiple proteases during Fas‐mediated apoptosis in T lymphocytes
Chow, S. C., Weis, M., Kass, G. E. N., Holmström, T. H., Eriksson, J., & Orrenius, S. (1995) · FEBS Letters · doi:10.1016/0014-5793(95)00370-o · Cited by 134
Zheng, L., Trageser, C., Willerford, D. M., & Lenardo, M. J. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.2.763 · Cited by 134
Self-citationPeripheral deletion of autoreactive CD8+ T cells in transgenic mice expressing H‐2Kb in the liver
Bertolino, P., Heath, W. R., Hardy, C. L., Morahan, G., & Miller, J. F. A. P. (1995) · European Journal of Immunology · doi:10.1002/eji.1830250721 · Cited by 133
Caspase activity is required for commitment to Fas‐mediated apoptosis
Longthorne, V. L., & Williams, G. T. (1997) · The EMBO Journal · doi:10.1093/emboj/16.13.3805 · Cited by 130
CD95 (APO-1/Fas) induces activation of SAP kinases downstream of ICE-like proteases.
Cahill, M. A., Peter, M. E., Kischkel, F. C., Chinnaiyan, A. M., Dixit, V. M., Krammer, P. H., & Nordheim, A. (1996) · PubMed · Cited by 128
Maria, R. D., Boirivant, M., Cifone, M. G., Roncaioli, P., Hahne, M., Tschopp, J., Pallone, F., Santoni, A., & Testi, R. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118418 · Cited by 128
Fas-induced apoptosis of T cells occurs independently of ceramide generation
Watts, J. D., Gu, M., Polverino, A. J., Patterson, S. D., & Aebersold, R. H. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.14.7292 · Cited by 127
Latinis, K. M., & Koretzky, G. A. (1996) · Blood · doi:10.1182/blood.v87.3.871.bloodjournal873871 · Cited by 124
TCR Antigen–Induced Cell Death Occurs from a Late G1 Phase Cell Cycle Check Point
Lissy, N. A., van Dyk, L. F., Becker‐Hapak, M., Vocero-Akbani, A. M., Mendler, J. H., & Dowdy, S. F. (1998) · Immunity · doi:10.1016/s1074-7613(00)80458-6 · Cited by 116
Death cycle and Swiss army knives
Hengartner, M. O. (1998) · Nature · doi:10.1038/35036 · Cited by 111
Razvi, E. S., Jiang, Z., Woda, B. A., & Welsh, R. M. (1995) · Europe PMC (PubMed Central) · Cited by 111
Choe, J., Kim, H. S., Zhang, X., et al. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.157.3.1006 · Cited by 111
Cock, J. G. R. B.-D., Tepper, A. D., de Vries, E., BLITTERSWIJK, W. J. V., & Borst, J. G. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.13.7560 · Cited by 109
Ohta, T., Kinoshita, T., Naito, M., Nozaki, T., Masutani, M., Tsuruo, T., & Miyajima, A. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.37.23111 · Cited by 107
TNF, Apoptosis and Autoimmunity: A Common Thread?
Beutler, B., & Bazzoni, F. (1998) · Blood Cells Molecules and Diseases · doi:10.1006/bcmd.1998.0187 · Cited by 107
Suppression of Fas/APO-1-Mediated Apoptosis by Mitogen-Activated Kinase Signaling
Holmström, T. H., Chow, S. C., Elo, I., Coffey, E. T., Orrenius, S., Sistonen, L., & Eriksson, J. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.6.2626 · Cited by 106
The ins and outs of programmed cell death during C. elegans development
Hengartner, M. O., & Horvitz, H. R. (1994) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.1994.0100 · Cited by 104
Fruman, D. A., Mather, P. E., Burakoff, S. J., & Bierer, B. E. (1992) · European Journal of Immunology · doi:10.1002/eji.1830221008 · Cited by 101
Portrait of an executioner: the molecular mechanism of Fas/APO-1-induced apoptosis
Chinnaiyan, A. M., & Dixit, V. M. (1997) · Seminars in Immunology · doi:10.1006/smim.1996.0055 · Cited by 98
Peripheral clonal deletion of antiviral memory CD8+ T cells
Moskophidis, D., Laine, E., & Zinkernagel, R. M. (1993) · European Journal of Immunology · doi:10.1002/eji.1830231237 · Cited by 97
Peripheral T-cell lymphoma in lckpr-bcl-2 transgenic mice
Linette, G. P., Hess, J. L., Sentman, C., & Korsmeyer, S. J. (1995) · Blood · doi:10.1182/blood.v86.4.1255.bloodjournal8641255 · Cited by 97
Novel Fas (CD95/APO-1) mutations in infants with a lymphoproliferative disorder.
Kasahara, Y., Wada, T., Niida, Y., Yachie, A., Seki, H., Ishida, Y., Sakai, T., Koizumi, F., Koizumi, S., Miyawaki, T., et al. (1998) · International Immunology · doi:10.1093/intimm/10.2.195 · Cited by 94
Kuroda, K., Yagi, J., Imanishi, K., Yan, X., Li, X. Y., Fujimaki, W., Kato, H., Miyoshi‐Akiyama, T., Kumazawa, Y., Abe, H., et al. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.157.4.1422 · Cited by 82
Gillette‐Ferguson, I., & Sidman, C. L. (1994) · European Journal of Immunology · doi:10.1002/eji.1830240526 · Cited by 80
Expression and function of Fas antigen on activated murine B cells
Wang, J., Taniuchi, I., Maekawa, Y., Howard, M., Cooper, M. D., & Watanabe, T. (1996) · European Journal of Immunology · doi:10.1002/eji.1830260114 · Cited by 80
Self-citationMolecular and Cellular Mechanisms of T Lymphocyte Apoptosis
Penninger, J. M., & Kroemer, G. (1998) · Advances in immunology · doi:10.1016/s0065-2776(08)60558-1 · Cited by 79
Immune Response and Myoblasts That Express Fas Ligand
Kang, S., Hofmann, A., Le, D., Springer, M. L., Stock, P. G., & Blau, H. M. (1997) · Science · doi:10.1126/science.278.5341.1322 · Cited by 78
Fournel, S., Genestier, L., Robinet, É., Flacher, M., & Révillard, J. P. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.157.10.4309 · Cited by 77
Introduction: The molecular regulation of lymphocyte apoptosis
Lenardo, M. J. (1997) · Seminars in Immunology · doi:10.1006/smim.1996.0050 · Cited by 75
Self-citationAntigen Receptor Signaling Gives Lymphocytes a Long Life
Neuberger, M. S. (1997) · Cell · doi:10.1016/s0092-8674(00)80362-1 · Cited by 73
T cell deletion follows chronic antigen specific T cell activation in vivo
Mamalaki, C., Tanaka, Y., Corbella, P., Chandler, P., Simpson, E., & Kioussis, D. (1993) · International Immunology · doi:10.1093/intimm/5.10.1285 · Cited by 71
The CD95 system and the death of a lymphocyte
Matiba, B., Mariani, S. M., & Krammer, P. H. (1997) · Seminars in Immunology · doi:10.1006/smim.1996.0054 · Cited by 68
Vandevoorde, V., Haegeman, G., & Fiers, W. (1997) · The Journal of Cell Biology · doi:10.1083/jcb.137.7.1627 · Cited by 67
Uchiumi, T., Wada, A., & Kominami, R. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.50.29889 · Cited by 66
Comparative molecular modelling of the Fas-ligand and other members of the TNF family
Peitsch, M. C., & Tschopp, J. (1995) · Molecular Immunology · doi:10.1016/0161-5890(95)00016-8 · Cited by 66
T Cell Receptor Signals Enhance Susceptibility to Fas-mediated Apoptosis
Wong, B., Arron, J. R., & Choi, Y. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.11.1939 · Cited by 65
White, C. A., McCombe, P., & Pender, M. P. (1998) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(97)00187-2 · Cited by 63
Proteolysis and the biochemistry of life-or-death decisions.
Ashkenas, J., & Werb, Z. (1996) · The Journal of Experimental Medicine · doi:10.1084/jem.183.5.1947 · Cited by 57
Evidence against an early signalling role for ceramide in Fas-mediated apoptosis
Sillence, D. J., & ALLAN, D. (1997) · Biochemical Journal · doi:10.1042/bj3240029 · Cited by 56
How do tumor necrosis factor receptors work?
Bazzoni, F., & Beutler, B. (1995) · PubMed · Cited by 55
Gonzalo, J. A., Baixerás, E., González-Garcı́a, A., George‐Chandy, A., van Rooijen, N., Martı́nez, C., & Kroemer, G. (1994) · The Journal of Immunology · doi:10.4049/jimmunol.152.4.1597 · Cited by 55
bcl-2 transgenic Lpr mice show profound enhancement of lymphadenopathy
Reap, E. A., Felix, N. J., Wolthusen, P. A., Kotzin, B. L., Cohen, P. L., & Eisenberg, R. A. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.155.11.5455 · Cited by 53
Pathways leading to cell death in T cells
Wong, B., & Choi, Y. (1997) · Current Opinion in Immunology · doi:10.1016/s0952-7915(97)80082-9 · Cited by 52
Kennedy, N. J., & Budd, R. C. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.10.4881 · Cited by 51
Radvanyi, L. G., Shi, Y., Mills, G. B., & Miller, R. G. (1996) · Cellular Immunology · doi:10.1006/cimm.1996.0160 · Cited by 51
Activation-induced apoptosis in lymphoid systems.
Green, D. R., Bissonnette, R. P., Glynn, J. M., & Shi, Y. (1992) · PubMed · Cited by 50
ALPS: an autoimmune human lymphoproliferative syndrome associated with abnormal lymphocyte apoptosis
Puck, J. M., & Sneller, M. C. (1997) · Seminars in Immunology · doi:10.1006/smim.1996.0056 · Cited by 49
Benacerraf, B., Greene, M. I., Sy, M., & Dorf, M. E. (1982) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1982.tb36115.x · Cited by 47
Segregation of APO‐1/Fas antigen‐ and tumor necrosis factor receptor‐mediated apoptosis
Grell, M., Krammer, P. H., & Scheurich, P. (1994) · European Journal of Immunology · doi:10.1002/eji.1830241045 · Cited by 45
Autoimmunity in Mice Bearing lprcs: A Novel Mutant Gene
Kimura, M., & Matsuzawa, A. (1994) · International Reviews of Immunology · doi:10.3109/08830189409061727 · Cited by 44
Molecules involved in cell death and peripheral tolerance
Wang, J., & Lenardo, M. J. (1997) · Current Opinion in Immunology · doi:10.1016/s0952-7915(97)80184-7 · Cited by 42
Self-citationAPO‐1(CD95)‐mediated apoptosis in Jurkat cells does not involve src kinases or CD45
Schraven, B. L., & Peter, M. E. (1995) · FEBS Letters · doi:10.1016/0014-5793(95)00720-t · Cited by 42
Smith, D. J., McGuire, M. J., Mj, T., & Thiele, D. L. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.158.1.163 · Cited by 41
TCR-mediated death of mature T lymphocytes occurs in the absence of p53
Boehme, S. A., & Lenardo, M. J. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.156.11.4075 · Cited by 38
Self-citationMemon, S. A., Hou, J., Moreno, M. B., & Zacharchuk, C. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.5.2046 · Cited by 37
Memon, S. A., Hou, J., Moreno, M. B., et al. (1998) · PubMed · Cited by 36
Ishigami, T., White, C. A., & Pender, M. P. (1998) · European Journal of Immunology · doi:10.1002/(sici)1521-4141(199805)28:05<1626::aid-immu1626>3.0.co;2-b · Cited by 35
Tamura, A., Katsumata, M., Greene, M. I., & Yui, K. (1996) · Cellular Immunology · doi:10.1006/cimm.1996.0069 · Cited by 26
Kang, S., Lin, Z., Ascher, N. L., & Stock, P. G. (1998) · Transplantation Proceedings · doi:10.1016/s0041-1345(97)01396-1 · Cited by 26
Wang, R., Ciardelli, T. L., & Russell, J. H. (1997) · Cellular Immunology · doi:10.1006/cimm.1997.1220 · Cited by 21
Heumann, D., Roy, D. L., Zanetti, G. M. R., et al. (1997) · PubMed · Cited by 21
Amelioration of Autoimmune Reactions by Antigen-Induced Apoptosis of T Cells
McFarland, H. I., Critchfield, J. M., Racke, M. K., et al. (1995) · Advances in experimental medicine and biology · doi:10.1007/978-1-4615-1891-4_18 · Cited by 19
Self-citationBlair, P. J., Boise, L., Perfetto, S. P., Levine, B. L., McCrary, G., Wagner, K. F., Louis, D. C. S., Thompson, C. B., Siegel, J. N., & June, C. H. (1997) · Journal of Clinical Immunology · doi:10.1023/a:1027310612323 · Cited by 15
Cell Cycle-Related Protein Kinases and T Cell Death
Lahti, J. M., Xiang, J., & Kidd, V. J. (1995) · Advances in experimental medicine and biology · doi:10.1007/978-1-4615-1885-3_27 · Cited by 4
Can expression of CD95 (Fas/APO-1) ligand on grafts or tumor cells prevent their rejection?
Allison, J., Seino, K., & Yagita∥, H. (1998) · Springer Seminars in Immunopathology · doi:10.1007/bf00787228 · Cited by 2
Signaling Through Fas (CD95, APO-1) and Related Death Receptors
Siegel, R. M., Martin, D. A., Hornung, F., Dudley, E. C., Zheng, L., & Lenardo, M. J. (2000) · Humana Press eBooks · doi:10.1007/978-1-59259-218-0_8 · Cited by 2
Self-citation
Cited by
A guide to cancer immunotherapy: from T cell basic science to clinical practice
Waldman, A. D., Fritz, J. M., & Lenardo, M. J. (2020) · Nature Reviews Immunology · doi:10.1038/s41577-020-0306-5 · Cited by 4,154
Self-citationThe TNF and TNF Receptor Superfamilies
Locksley, R. M., Killeen, N., & Lenardo, M. J. (2001) · Cell · doi:10.1016/s0092-8674(01)00237-9 · Cited by 3,650
Self-citationCaspase Functions in Cell Death and Disease
McIlwain, D. R., Berger, T., & Mak, T. W. (2013) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a008656 · Cited by 2,594
Overview of cell death signaling pathways
Jin, Z., & El-Deiry, W. S. (2005) · Cancer Biology & Therapy · doi:10.4161/cbt.4.2.1508 · Cited by 1,326
Pandiyan, P., Zheng, L., Ishihara, S., Reed, J., & Lenardo, M. J. (2007) · Nature Immunology · doi:10.1038/ni1536 · Cited by 1,286
Self-citation
Metadata
- Authors
- Lenardo, M., Chan, F. K.-M., Hornung, F., McFarland, H., Siegel, R., Wang, J., & Zheng, L.
- Venue
- Annual Review of Immunology
- Publisher
- Annual Reviews
- Published
- 1999-04
- Volume
- 17
- Issue
- 1
- Pages
- 221-253
- ISSN
- 0732-0582 (ISSN-L)
- 1545-3278
- OpenAlex
- W2159531745
- Cited by
- 943
- References
- 305
- FWCI
- 6.12
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.